
Cancer & Hyperbarics
In 2021, over 1.9 million people were diagnosed with cancer and over 610,000 cancer-related deaths occurred in the United States alone. Furthermore, cancer is a leading cause of death, worldwide, causing nearly 1 in 6 deaths in 2020.
New integrated treatments are being utilized to help combat cancer and its disease progression. Hyperbaric therapy is currently being utilized in conjunction with conventional treatments, including radiation and chemotherapy, to attain optimal dosages for patients, stimulate tumor regression and reduce the side effects of treatments.
Cancer thrives in hypoxic environments and hyperbaric therapy has been shown to increase these oxygen levels to weaken tumors and reduce their aggressiveness.
Source: International Hyperbarics Association. www.ihausa.org. Accessed 8 May 2024
Cancer Prevention
-
Decreases Inflammatory Markers
-
Normalizes Intracellular Oxygen Levels
-
Stimulates Cellular Detoxification
-
Reduces Risk of Pathogenic Inflammatory-Related Tumors
-
Supports Cellular Energy Processes for Optimal DNA Repair
Mental Health & Wellness
-
Enhances Memory and Mental Performance
-
Develops & Regains Cognitive/Motor Functions
-
Stimulates Neuroplasticity
-
Enhances Executive Function
Enhance “Conventional” Cancer Therapies & Treatment
-
Reduces Tumor Hypoxia
-
Better Radiation Therapy Results
-
Improves Chemotherapy Outcome
-
Enhances Brain Treatment
-
Decreases Tumor Drug Resistance
-
Allows for Optimal Therapy Dosage to be Attained
Increase Natural Killer Cell Activity and Function
-
Increases Oxy-Radical Production
-
Amplifies Apoptosis Effect
-
Regresses Tumor Volume
Reduce Side Effects of “Conventional” Cancer Therapies & Treatment
-
Reduces Radiation Therapy Side Effects
-
Decreases Chemotherapy Side Effects
-
Accelerates Post-Operative Healing & Prevents Infection
-
Reduces Chemo-Brain Syndrome Symptoms
Enhance IV Cancer Treatments
-
Increases Intravenous Vitamin C Therapy Effect
-
Enhances Chemotherapy Uptake
Reduce Tumor Aggressiveness
-
Weakens Hypoxic Tumors
-
Targets Metastatic Tumors